Literature DB >> 2542331

Cleavage of synthetic peptides by purified poliovirus 3C proteinase.

P V Pallai1, F Burkhardt, M Skoog, K Schreiner, P Bax, K A Cohen, G Hansen, D E Palladino, K S Harris, M J Nicklin.   

Abstract

Synthetic peptides, 14-16 residues in length, were used as substrates for purified recombinant poliovirus proteinase 3C. The sequences of the substrates correspond to the sequences of authentic cleavage sites in the poliovirus polyprotein, all of which contain Gln-Gly at the scissile bond. Specificity of cleavages was demonstrated by analysis of 3C digests of synthetic peptides. Relative rate constants for the cleavages were derived by competition experiments. The rate constants roughly correlated with the estimated half-life of the homologous precursor proteins detected in poliovirus-infected cells. The peptide most resistant to cleavage corresponded to the 3C/3D junction, a site known to be cleaved very slowly by 3C in vivo. Substitution of threonine for alanine in P4 position of this peptide, however, resulted in significant cleavage. This observation supports the hypothesis that the residue in P4 position, in addition to the Gln-Gly in P1 and P1', respectively, contributes to substrate recognition. Ac-Gln-Gly-NH2 was not a substrate for 3C.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542331

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3C(pro).

Authors:  Sung Hoon Back; Yoon Ki Kim; Woo Jae Kim; Sungchan Cho; Hoe Rang Oh; Jung-Eun Kim; Sung Key Jang
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  cis-acting lesions targeted to the hydrophobic domain of a poliovirus membrane protein involved in RNA replication.

Authors:  C Giachetti; S S Hwang; B L Semler
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase.

Authors:  K S Harris; S R Reddigari; M J Nicklin; T Hämmerle; E Wimmer
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Cellular protein modification by poliovirus: the two faces of poly(rC)-binding protein.

Authors:  Rushika Perera; Sarah Daijogo; Brandon L Walter; Joseph H C Nguyen; Bert L Semler
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

5.  Flavivirus enzyme-substrate interactions studied with chimeric proteinases: identification of an intragenic locus important for substrate recognition.

Authors:  F Preugschat; E M Lenches; J H Strauss
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase.

Authors:  W S Blair; B L Semler
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Functional characterization of the cleavage specificity of the sapovirus chymotrypsin-like protease.

Authors:  Ivonne Robel; Julia Gebhardt; Jeroen R Mesters; Alexander Gorbalenya; Bruno Coutard; Bruno Canard; Rolf Hilgenfeld; Jacques Rohayem
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

Review 8.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

9.  In vitro proteolytic processing of the MD145 norovirus ORF1 nonstructural polyprotein yields stable precursors and products similar to those detected in calicivirus-infected cells.

Authors:  Gaël Belliot; Stanislav V Sosnovtsev; Tanaji Mitra; Carl Hammer; Mark Garfield; Kim Y Green
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  3C-like protease of rabbit hemorrhagic disease virus: identification of cleavage sites in the ORF1 polyprotein and analysis of cleavage specificity.

Authors:  C Wirblich; M Sibilia; M B Boniotti; C Rossi; H J Thiel; G Meyers
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.